have proved that SNX-2112, the Hsp90 inhibitor, enhanced TRAIL-induced apoptosis and autophagy of cervical cancer cells through activating the ROS-regulated JNK-p53-autophagy-DR5 pathway (26); Zhu et al. The gene discussed is TP53; the disease is cervical carcinoma.